Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LLLT and Minoxidil for Chemotherapy-Induced Alopecia in Breast Cancer
NCT07594678Phase 2Not yet recruiting
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Nov 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoint: Dean scale score at 6 months. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07594678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07594678.